Overview

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Status:
RECRUITING
Trial end date:
2027-07-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of Baricitinib in the treatment of frontal fibrosing alopecia (FFA).
Phase:
PHASE4
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
Eli Lilly and Company
Treatments:
baricitinib